To explore the molecular mechanism of RBBP5 in melanoma cells, we analyzed the expression of β-catenin and c-myc, two marked target genes of the Wnt/β-catenin signalling pathway, in A375 and A2058 cells. The gene discussed is RBBP5; the disease is melanoma.